Dr Cassia Kessler Iglesias (@cassia_kessler) 's Twitter Profile
Dr Cassia Kessler Iglesias

@cassia_kessler

Wife, Mother, Daughter, Sister, Friend, Christian, Brazilian-Aussie Cardiologist, Researcher, Beach lover.

ID: 1374605679030247429

calendar_today24-03-2021 06:15:22

26 Tweet

46 Followers

86 Following

Victor Chang Cardiac Research Institute (@victorchanginst) 's Twitter Profile Photo

Huge thanks to #AFib sufferer Warren Williams who shared his story with Angelique Opie 7NEWS Sydney We hope Prof Diane @FatkinLab's research into the genetic causes of this disease will help identify those most at risk: youtube.com/watch?v=bPP0O4… hearts4heart Heart Foundation

Scott Cameron 🏴󠁧󠁢󠁳󠁣󠁴󠁿🇺🇸🫀🩺📟🔬🧫🧬🥋 (@2scottish) 's Twitter Profile Photo

🔥One of the best 🫀 #HeartFailure pharmacology slides I have ever seen. See how BB and ACEI separate? What digoxin does to risk? And the amazing impact of ARNI ! jacc.org/doi/abs/10.101…. #MedEd

🔥One of the best 🫀 #HeartFailure pharmacology slides I have ever seen.  See how BB and ACEI separate?  What digoxin does to risk?  And the amazing impact of ARNI ! jacc.org/doi/abs/10.101….  #MedEd
MOCERI Pamela (@moceripamela1) 's Twitter Profile Photo

New #ESCguidelines #ESC2022 mPAP threshold ⬇️ to 20mmHg and PVR ⬇️⬇️ 2 WU !! And Exercise PH Haemodynamic definition ! 🫁🫀Back to medical charts … #checkRight European Society of Cardiology SFC - Société Française de Cardiologie

New #ESCguidelines #ESC2022 mPAP threshold ⬇️ to 20mmHg and PVR ⬇️⬇️ 2 WU !! And Exercise PH Haemodynamic definition ! 🫁🫀Back to medical charts … #checkRight <a href="/escardio/">European Society of Cardiology</a> <a href="/SFCardio/">SFC - Société Française de Cardiologie</a>
Marta Farrero (@martafarrero) 's Twitter Profile Photo

No benefit of percutaneous revascularization in patiens with coronary disease, EF<35% and viablility in the REVIVED trial 😰#HFA #ESCCongress

No benefit of percutaneous revascularization in patiens with coronary disease, EF&lt;35% and viablility in the REVIVED trial 😰#HFA #ESCCongress
European Society of Cardiology (@escardio) 's Twitter Profile Photo

#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease. #ESCCongress

#REVIVED trial: Percutaneous coronary intervention does not reduce all-cause mortality or #heartfailure hospitalisation in patients with severe left ventricular dysfunction and extensive #coronary artery disease.

#ESCCongress
European Society of Cardiology (@escardio) 's Twitter Profile Photo

#DELIVER trial: dapagliflozin reduces the risk of #cardiovascular death or worsening #heartfailure in HF patients with mildly reduced and preserved ejection fraction. #ESCCongress

#DELIVER trial: dapagliflozin reduces the risk of #cardiovascular death or worsening #heartfailure in HF patients with mildly reduced and preserved ejection fraction. 

#ESCCongress
Victor Chang Cardiac Research Institute (@victorchanginst) 's Twitter Profile Photo

GPs, specialists, specialist nursing staff, and advanced trainees are invited to a Cardiac Amyloidosis Educational Day on May 9 at Coffs Harbour Public Hospital, run by the St Vincent’s Amyloid service. Register here: surveymonkey.com/r/WL63YR8 Dr Cassia Kessler Iglesias A/Prof. Nikki Bart BSc MBBS FRACP FCSANZ DPhil

American College of Cardiology (@accintouch) 's Twitter Profile Photo

🆕 2024 Guideline for the Management of HCM A key message from the guideline is the growing evidence regarding the beneficial effects of exercise for patients w/ HCM. Read the full guideline here: bit.ly/3WzVIn6

🆕 2024 Guideline for the Management of HCM

A key message from the guideline is the growing evidence regarding the beneficial effects of exercise for patients w/ HCM. 

Read the full guideline here: bit.ly/3WzVIn6
Dr Cassia Kessler Iglesias (@cassia_kessler) 's Twitter Profile Photo

Proud to be first author of this excellent work between the Htx teams at @SVHSydney and The Alfred Early Use of Aspirin for Coronary Allograft Prophylaxis in... : Transplantation journals.lww.com/transplantjour…